Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2009, 153(1):19-25 | DOI: 10.5507/bp.2009.003
MOLECULAR PATHOPHYSIOLOGY OF THROMBOTIC STATES AND THEIR IMPACT TO LABORATORY DIAGNOSTICS
- a Department of Hemato-oncology, University Hospital, Olomouc, Czech Republic
- b Department of Obstetrics and gynecology, University Hospital, Olomouc, Czech Republic
BACKGROUND: Molecular genetic methods were implemented in the detection of thrombophilic disorders in the 1990's with the discovery of coagulation inhibitors antithrombin III (AT III), protein C (PC) and S (PS). The discovery of the molecular cause of activated protein C (APC) resistance by Bertina in 1994 greatly expanded their utilization.
METHODS AND RESULTS: Currently, a broad group of molecular genetic markers with a clearly demonstrated risk of thrombophilia are used - mutation of FV Leiden 506R/Q, mutation of prothrombin (F II) 20210G/A, mutation of methylenetetrahydrofolate reductase (MTHFR) 677C/T in homozygous form, mutation of plasminogen activator inhibitor (PAI-1) 4G/5G, mutations of single coagulation inhibitors as well as a number of polymorphisms with controversial thrombophilic risk such as F XIII Val34Leu, platelet glycoproteins, endothelial protein C receptor and thrombomodulin. Another area utilizing molecular genetic methods is research of the pathophysiology of individual coagulation processes. To date, the greatest advances in regard to APC resistance have been achieved here. Although the molecular cause of APC resistance was clearly demonstrated in the 1990's, its clinical variability has not yet been fully explained. The same is true for the second most widespread mutation, prothrombin gene mutation, where only the latest research has hinted at a possible mechanism of expression of the genetic changes in the actual coagulation process.
CONCLUSIONS: The future of molecular genetic methods is in achieving a complex understanding of the pathophysiology of thrombophilia and not only in its utilization as a method for detecting many polymorphisms with a very low risk of thrombosis.
Keywords: Thrombophilia, Genetic causes of thrombophilia, FV Leiden
Received: April 24, 2008; Accepted: December 10, 2008; Published: March 1, 2009 Show citation
ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |
References
- Reitsma PH, Rosendaal FR. Past and future of genetic research in thrombosis. J Thromb Haemost. 2007, Jul 5; Suppl 1:264-9.
Go to original source...
Go to PubMed...
- Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet. 346, 1995, 1133-1134.
Go to original source...
Go to PubMed...
- Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood. 85, 1995, 1504-1508.
Go to original source...
- Ridker PM, Miletich JP, Hennekens CH, Buring JE. Ethnic distribution of factor V Leiden in 4047 men and women. JAMA. 277, 1997, 1305-1307.
Go to original source...
Go to PubMed...
- Vorlova Z., Hrachovinova I., Matyskova M. Probability of thrombosis in patients with factor V Leiden. Thromb.Haemost. 78:1, 1997, 309.
- Chrobák, L., Dulíček, P.: Resistance to activated protein C as pathogenic factor of venous thromboembolism. - Acta Medica (Hradec Králové). - 39,(2), 1996, 55-62.
- Dulicek P., Safarova M., Chrobak L. Mutace FV Leiden nejcastejsi rizikovy faktor pro vznik ziln i trombozy. Hematologia a transfuziologia. 4, 1997, 6-9.
- Bertina RM, Koeleman RPC, Koster T, Rosendaal FR, Dirven RJ, De Ronde H, Van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 369, 1994, 64-67.
Go to original source...
Go to PubMed...
- Dahlback B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognised mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA. 90, 1993, 1004-1008.
Go to original source...
Go to PubMed...
- Koster T, Rosendaal FR, De Ronde H, Briet E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to a poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet. 342, 1993, 1503-1506.
Go to original source...
Go to PubMed...
- Ridker PM, Hennekens CH, Lindpainter K, Stampfer MJ, Eisenberg PR, Miletich JP. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med. 332, 1995, 912-917.
Go to original source...
Go to PubMed...
- Anderson FA, Wheeler HB, Goldberg RJ, Hosmer DW, Patwardhan NA, Jovanovic B, Forrier A, Dalen JE. A population based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT study. Arch Intern Med. 151, 1991, 933-938.
Go to original source...
Go to PubMed...
- Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A commongenetic variation in the 3-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 88, 1996, 3698-3703.
- Rosendaal FR, Doggen CJM, Zivelin A, Arruda VR, Aiach M, Siscovick DS, Hillarp A, Watzke HH, Bernardi F, Cumming AM, Preston FE, Reitsma PH. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost. 79, 1998, 706-708.
Go to original source...
Go to PubMed...
- Matyskova M., Bulikova A., Slechtova M., Janku L. The prevalence of the prothrombin mutation 20210A in Brno , XV meeting of the ISH - African and European division, Final programme and abstracts, 124.
- Souto JC, Coll I, Llobet D, del Rio E, Oliver A, Mateo J, Borrell M, Fontcuberta J. The prothrombin 20210A allele is the most present genetic risk factor for venous thromboembolism in the Spanish population. Thromb Haemost. 80, 1998, 366-369.
Go to original source...
Go to PubMed...
- Falcon CR, Cattaneo M, Panzeri D, Martinelli I, Mannucci PM. High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis. Arterioscler Thromb. 14, 1994, 1080-1083.
Go to original source...
Go to PubMed...
- Den Heijer M, Koster T, Blom HJ, Bos GMJ, Briet E, Reitsma PH, Vandenbroucke JP, Rosendaal FR. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med. 334, 1996, 759-762.
Go to original source...
Go to PubMed...
- Simioni P, Prandoni P, Burlina A, Tormene D, Sardella C, Ferrari V, Benedetti L, Girolami A. Hyperhomocysteinemia and deep-vein thrombosis: a case-control study. Thromb Haemost. 76, 1996, 883- 886.
Go to original source...
Go to PubMed...
- Hyánek J., Hoffman R. Hyperhomocysteinémie a její diagnostický význam u cévních onemocnění. Praktická flebologie. 2, 1997, 61-71.
- DAngelo A, Selhub J. Homocysteine and thrombotic disease. Blood. 90, 1997, 1-11.
Go to original source...
- Kang SS, Wong PWK, Norusis M. Homocysteinemia due to folate deficiency. Metabolism. 36, 1987, 458-462.
Go to original source...
Go to PubMed...
- Kang SS, Wong PWK, Norusis M. Homocysteinemia due to folate deficiency. Metabolism. 36, 1987, 458-462.
Go to original source...
Go to PubMed...
- Rees MM, Rodgers GM. Homocysteinemia: association of a metabolic disorder with vascular disease and thrombosis. Thrombosis Research. 71, 1993, 337-359.
Go to original source...
Go to PubMed...
- Ubbink JB, Vermaak WJ, Van der Merwe A, Becker PJ. Vitamin B12, vitamin B6, and folate nutritional status in men with hyperhomocysteinemia. Am J Clin Nutr. 57, 1993, 47-53.
Go to original source...
Go to PubMed...
- Mudd SH, Skovby F, Levy HL, Pettigrew KD, Wilcken B, Pyeritz RE, Andria G, Boers GH, Bromberg IL, Cerone R. The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet. 37, 1985, 1-31.
- Engbertsen AMT, Franken DG, Boers GHJ, Stevens EMB, Grijbels FJM, Blom HJ. Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am J Hum Genet. 56, 1995, 142-150.
- Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GHJ, Den Heijer M, Kluijtmans LAJ, Van den Heuvel LPWJ, Rozen R. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 10, 1995, 111-113.
Go to original source...
Go to PubMed...
- Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thromb Diath Haemorrh. 13, 1965, 516-530.
Go to original source...
Go to PubMed...
- Thaler E, Lechner K. Antithrombin III deficiency and thromboembolism. Clin Haematol. 10, 1981, 369-390.
Go to original source...
- Demers C, Ginsberg JS, Hirsh J, Henderson P, Blajchman MA. Thrombosis in antithrombin III deficient persons: report of a large kindred and literature review. Ann Intern Med. 116, 1992, 754-761.
Go to original source...
Go to PubMed...
- Hirsh J, Piovella F , Pini M. Congenital antithrombin III deficiency: incidence and clinical features. Am J Med. 87, 1989, 34-38.
Go to original source...
Go to PubMed...
- Lane DA, Mannucci PM, Bauer KA, Bertina RM, Bochkov NP, Boulyjenkov V, Chandy M, Dahlback B, Ginter EK, Miletich JP, Rosendaal FR, Seligsohn U. Inherited Thrombophilia: Part 1. Thromb Haemost. 76, 1996, 651-662.
Go to original source...
Go to PubMed...
- Tait RC, Walker ID, Perry DJ, Islam SI, Daly ME, McCall F, Conkie JA, Carrell RW. Prevalence of antithrombin deficiency in the healthy population. Br J Haematol. 87, 1994, 106-112.
Go to original source...
Go to PubMed...
- Bock, S.C. et al.: Assignement of the huan antithrombin III structual gene to chromosome 1q23-25. Cytogenet. Cell Genet., 39, 1985, 67-69.
Go to original source...
Go to PubMed...
- Lane D.A. et al.: Antithrombin III: A database of mutations. Thrombos. Haemostasis, 66, 1991, 657661.
- Griffin JH, Evatt B, Zimmerman TS, Kleiss AJ, Wideman C. Deficiency of protein C in congenital thrombotic disease. J Clin Invest. 68, 1981, 1370-1373.
Go to original source...
Go to PubMed...
- Allaart CF, Poort SR, Rosendaal FR, Reitsma PH, Bertina RM, Briet E. Increased risk of venous thrombosis in carriers of protein C deficiency defect. Lancet. 341, 1993, 134-138.
Go to original source...
Go to PubMed...
- Broekmans AW, Veltkamp JJ, Bertina RM. Congenital protein C deficiency and venous thromboembolism: a study of three Dutchfamilies. N Engl J Med. 309, 1983, 340-344.
Go to original source...
Go to PubMed...
- Allaart CF, Poort SR, Rosendaal FR, Reitsma PH, Bertina RM, Briet E. Increased risk of venous thrombosis in carriers of protein C deficiency defect. Lancet. 341, 1993, 134-138.
Go to original source...
Go to PubMed...
- Koeleman BPC, Reitsma PH, Allaart CF, Bertina RM. APCresistance as an additional risk factor for thrombosis in protein C deficient families. Blood. 84, 1994, 1031-1035.
Go to original source...
- Heijboer H, Brandjes DPM, Buller HR, Sturk A, Ten Cate JW. Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis. N Engl J Med. 323, 90,1512- 1516.
Go to original source...
Go to PubMed...
- Mateo J, Oliver A, Borrell M, Sala N, Fontcuberta J, the EMET Group. Laboratory evaluation and clinical characteristics of 2,132 consecutive unselected patients with venous thromboembolismresults of the Spanish multicentric study on thrombophilia(EMETstudy). Thromb Haemost. 77, 997,444-451.
Go to PubMed...
- Koster T, Rosendaal FR, Briet E, Van der Meer FJM, Colly LP, Trienekens PH, Poort SR, Vandenbroucke JP. Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis (Leiden hrombophilia Study). Blood. 85, 1995, 2756-2761.
Go to original source...
- Reitsma PH, Bernardi F, Doig RG, Gandrille S, Greengard JS, Ireland H, Krawczak M, Lind B, Long GL, Poort SR, Saito H, Sala N, Witt I, Cooper DN. Protein C deficiency a database of mutations. 1995 Update. Thromb Haemost. 73, 1995, 876-889.
Go to original source...
Go to PubMed...
- Walker I.D. et al. Guidelines on the Investigation ona Management of Thrombophilia. J. Clin Path, 43, 1990, 703-709.
Go to original source...
Go to PubMed...
- Cripe LD, Moore KD, Kane WH. Structure of the gene for human coagulation factor V. Biochemistry 1992; 31:3777-3785.
Go to original source...
Go to PubMed...
- Jenny RJ, Pittman DD, Toole JJ, et al. Komplete cDNA and derived amino acid sequence of human factor V. Proc Natl Acad Sci USA 1987; 84:4846-4850.
Go to original source...
Go to PubMed...
- Tracy PB, Eide LL, Bowie EJ, et al. Radioimmunoassay of factor V in human plasma and platelets. Blood 1982; 60:59-63.
Go to original source...
- Suehiro Y, Veljkovic DK, Fuller N, et al. Endocytosis and storage of plasma factor V by human megakaryocytes. Thromb Haemost 2005; 94:585-592.
Go to original source...
Go to PubMed...
- Hoekema L, Nicolaes GAF, Hemker HC, et al. Human factor Va1 and factor Va2: properties in the procoagulant and anticoagulant pathways. Biochemistry 1997; 36:3331-3335.
Go to original source...
Go to PubMed...
- Esmon CT. The subunit structure of thrombin-activated factor V. Isolation of activated factor V, separation of subunits, and reconstitution of biological activity. J Biol Chem 1979; 254:964-973.
Go to original source...
- Husten EJ, Esmon CT, Johnson AE. The active site of blood coagulation factor Xa. Its distance from the phospholipid surface and its conformational sensitivity to components of the prothrombinase complex. J Biol Chem 1987; 262:12953-12961.
Go to original source...
- Yegneswaran S, Fernandez JA, Griffin JH, et al. Factor Va increases the affinity of factor Xa for prothrombin: a binding study using a novel photoactivable thiol-specific fluorescent probe. Chem Biol 2002; 9: 485494.
Go to original source...
- Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90:10041008.
Go to original source...
- Bertina RM, Koeleman BP, Koster T, et al. Mutation in blood coagulation factor V associated with resistence to activated protein C. Nature 1994; 369:6467.
Go to original source...
Go to PubMed...
- Leroy-Matheron C, Mallat A, Duvoux C, et al. Inhibitor against coagulation factor V after liver transplantation. Transplantation 1999; 68: 10541056.
Go to original source...
Go to PubMed...
- Reitsma PH, Rosendaal FR. Past and future of genetic research in thrombosis. J Thromb Haemost. 2007 Jul;5 Suppl 1:264-9
Go to original source...
Go to PubMed...
- Segers K., Dahlbäck B, Nicolaes G. Coagulation factor V and thrombophilia: Background and mechanisms. Thromb Haemost 2007; 98: 530542
Go to original source...
Go to PubMed...